Aarey Drugs & Pharmaceuticals Limited
NSE:AAREYDRUGS.NS
62.78 (INR) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||
Current Assets: | ||||||||||||||||
Cash & Cash Equivalents
| 15.944 | 7.058 | 1.919 | 6.367 | 4.873 | 3.455 | 5.237 | 10.379 | 16.217 | 1.715 | 8.488 | 5.095 | 11.42 | 3.792 | 1.622 | 3.961 |
Short Term Investments
| 12.957 | 4.18 | 75.068 | 0.13 | 0.154 | 0.233 | 28.66 | 4.338 | 0 | 0.4 | 0.4 | 0.4 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 15.944 | 11.238 | 1.919 | 6.497 | 5.027 | 3.687 | 33.897 | 10.379 | 16.217 | 1.715 | 8.488 | 5.095 | 11.42 | 3.792 | 1.622 | 3.961 |
Net Receivables
| 1,999.919 | 1,987.921 | 2,123.835 | 1,992.408 | 1,637.924 | 1,112.941 | 1,390.183 | 845.994 | 744.72 | 683.047 | 688.036 | 679.702 | 560.435 | 333.755 | 0 | 0 |
Inventory
| 346.757 | 288.192 | 136.839 | 184.606 | 169.96 | 212.504 | 147.75 | 52.102 | 20.764 | 41.664 | 51.308 | 75.183 | 81.228 | 34.829 | 47.369 | 30.104 |
Other Current Assets
| 463.331 | 418.706 | 0.643 | 0.264 | 0.528 | 0.792 | 1.056 | 398.334 | 385.367 | 359.431 | 268.792 | 233.852 | 165.8 | -0 | 159.4 | 81.725 |
Total Current Assets
| 2,825.951 | 2,706.057 | 2,263.236 | 2,183.775 | 1,813.44 | 1,329.924 | 1,572.886 | 1,306.809 | 1,167.069 | 1,085.857 | 1,016.624 | 993.832 | 818.882 | 372.377 | 208.392 | 115.789 |
Non-Current Assets: | ||||||||||||||||
Property, Plant & Equipment, Net
| 146.591 | 139.368 | 144.666 | 142.581 | 123.393 | 123.146 | 120.948 | 121.455 | 78.506 | 58.923 | 47.15 | 44.086 | 48.21 | 54.032 | 52.796 | 38.231 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 77.379 | 4.084 | 27.969 | 4 | 4 | 4.004 | -24.656 | 4.668 | 4.4 | 4 | 4 | 31.9 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | -143.452 | 15.817 | -146.581 | 0 | 0.081 | 28.741 | -0.268 | 0 | 0.714 | 1.116 | 1.341 | 1.27 | 0.228 | 0.016 | 0.016 |
Total Non-Current Assets
| 223.97 | 207.187 | 188.452 | 146.581 | 127.393 | 127.23 | 125.032 | 125.855 | 82.906 | 63.636 | 52.266 | 77.327 | 49.48 | 54.26 | 52.812 | 38.247 |
Total Assets
| 3,049.921 | 2,913.245 | 2,451.688 | 2,330.357 | 1,940.832 | 1,457.154 | 1,697.918 | 1,432.664 | 1,249.974 | 1,149.493 | 1,068.889 | 1,071.159 | 868.363 | 426.637 | 261.204 | 154.037 |
Liabilities & Equity: | ||||||||||||||||
Current Liabilities: | ||||||||||||||||
Account Payables
| 1,289.43 | 1,273.29 | 1,096.615 | 1,103.399 | 777.497 | 372.785 | 775.793 | 745.473 | 719.451 | 671.438 | 640.807 | 677.272 | 480.751 | 0 | 0 | 0 |
Short Term Debt
| 281.279 | 333.575 | 141.625 | 180.172 | 178.684 | 161.164 | 31.795 | 103.198 | 144.479 | 110.199 | 57.016 | 46.913 | 44.137 | 0 | 2.602 | 0 |
Tax Payables
| 13.25 | 17.832 | 27.418 | 2.531 | 17.948 | 2.177 | 0.784 | 24.493 | 11.435 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 13.25 | 52.798 | 52.31 | 42.549 | 46.447 | 41.95 | 73.694 | 33.247 | 11.863 | 10.929 | 10.349 | 8.837 | 8.591 | 0 | 0 | 0 |
Other Current Liabilities
| 98.49 | 21.686 | 10.212 | -0 | 0.15 | 0.425 | 0.65 | 46.423 | 6.333 | 2.837 | 15.363 | 1.741 | 6.591 | 174.644 | 122.781 | 55.031 |
Total Current Liabilities
| 1,682.45 | 1,681.349 | 1,300.762 | 1,326.12 | 1,002.778 | 576.324 | 881.932 | 928.34 | 882.126 | 795.403 | 723.535 | 734.763 | 540.071 | 174.644 | 125.383 | 55.031 |
Non-Current Liabilities: | ||||||||||||||||
Long Term Debt
| 32.244 | 43.606 | 33.4 | 0 | 0.191 | 0.386 | 0.564 | 0.725 | 0.875 | 0 | 0.142 | 1.693 | 0.172 | 32.942 | 43.741 | 15.031 |
Deferred Revenue Non-Current
| -7.494 | 0 | -33.4 | 0 | 0 | 0 | -12.975 | -30.672 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 7.494 | 14.151 | 14.554 | 15.632 | 14.402 | 14.918 | 12.975 | 15.336 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 7.494 | 0.001 | 0 | 0 | -0 | -0 | 12.975 | 15.336 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 39.738 | 57.758 | 14.554 | 15.632 | 14.593 | 15.304 | 13.539 | 0.725 | 0.875 | 0 | 0.142 | 1.693 | 0.172 | 32.942 | 43.741 | 15.031 |
Total Liabilities
| 1,722.187 | 1,739.107 | 1,315.316 | 1,341.752 | 1,017.371 | 591.628 | 895.471 | 929.066 | 883.001 | 795.403 | 723.677 | 736.456 | 540.243 | 207.586 | 169.124 | 70.062 |
Equity: | ||||||||||||||||
Preferred Stock
| 0 | 1,148.988 | 0 | 0 | 898.312 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 280.543 | 253.847 | 253.847 | 233.847 | 233.847 | 233.847 | 233.847 | 180.847 | 168.147 | 168.147 | 168.147 | 168.147 | 140.122 | 50.004 | 50.004 | 50.004 |
Retained Earnings
| 531.259 | 484.245 | 446.534 | 381.086 | 315.943 | 258.007 | 194.928 | 148.488 | 89.674 | 76.791 | 67.912 | 57.403 | 50.82 | 47.981 | 40.076 | 31.971 |
Accumulated Other Comprehensive Income/Loss
| 24.65 | 25.15 | 25.15 | 25.15 | 25.15 | 25.15 | 25.15 | 12.307 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 |
Other Total Stockholders Equity
| 491.282 | -738.092 | 410.842 | 348.522 | -549.79 | 348.522 | 348.522 | 161.957 | 107.153 | 107.153 | 107.153 | 107.153 | 137.178 | 121.065 | 2 | 2 |
Total Shareholders Equity
| 1,327.734 | 1,174.138 | 1,136.373 | 988.605 | 923.462 | 865.526 | 802.447 | 503.599 | 366.973 | 354.091 | 345.212 | 334.702 | 328.12 | 219.05 | 92.08 | 83.975 |
Total Equity
| 1,327.734 | 1,174.138 | 1,136.373 | 988.605 | 923.462 | 865.526 | 802.447 | 503.599 | 366.973 | 354.091 | 345.212 | 334.702 | 328.12 | 219.05 | 92.08 | 83.975 |
Total Liabilities & Shareholders Equity
| 3,049.921 | 2,913.245 | 2,451.688 | 2,330.357 | 1,940.832 | 1,457.154 | 1,697.918 | 1,432.664 | 1,249.974 | 1,149.493 | 1,068.889 | 1,071.159 | 868.363 | 426.637 | 261.204 | 154.037 |